Healthcare News

Zycov-D is developed by Zydus Cadila and it has been approved for emergency use for Covid-19 in India.   India has already approved 5 vaccines and now ZyCov-D is also approved for emergency use in India. ZyCov-D has been tested and can be given to children and adults 12 years and above. Zydus Cadila has approved Zycov-D vaccine for Phase III clinical trials under the Department of Biotebiotechnology by the Drug Controller General of India (DCGI) in Zydus Cadila. Cadila Healthcare will begin the Phase II trials of the vaccine candidate on August 6, 2021, as part of an adaptive multicentre dose increase in phase I / II using randomized, placebo-controlled methods. The company also confirmed that a second candidate vaccine, ZycoV-MV, targeting COVID-19, has completed pragmatic clinical trials in non-human primate immunogenicity studies and will be presented shortly.  Key Pointers about ZyCov-D Vaccine: ZyCov-D is the world’s first Plasmid DNA Vaccine for Covid-19 ZyCov-D Vaccine ...

In recent years, the use of Artificial Intelligence and Internet of Things in healthcare industry has increasingly attracted great attention. This is because these technologies are able to detect the potential risks and inefficiencies of current healthcare practices, which can lead to new business models as well as improved patient care. In this article, we will explore different AI applications and their core components. With a detailed introduction on what each application does for us and its benefits for healthcare industry.  Artificial Intelligence and Healthcare Cancer diagnosis is one of the applications which can benefit greatly from AI and IoT. First, AI allows doctors to get a biological sample from a patient and run it through prediction algorithms to make a "virtual biopsy" of that patient's cancer. These algorithms then create images that show the doctor how far the cancer has spread. With AI's powerful analysis in healthcare, it can help doctors mak...